d-light-trade´s high-quality food supplements and supplements for the complementary treatment of auto-immune diseases and nutritional deficiencies are made in Germany. All products meet the latest standards for pharmaceutical production – to support your health.
All of d-light-trade´s production operations are carried out in German facilities. This means that the producers are subject to the strict provisions of German and European law. Regular controls ensure that production meets the highest standards at all times.
Complementary treatments can only be successful if they are based on medical expertise. This is why doctors and biochemists from the field of orthomolecular medicine advise d-light-trade on the range and composition of its products.
Anyone who wants to improve human health should also be sparing with the resources of our planet. That is why our laboratory-tested ingredients come from organic sources – where possible and practical. In addition, nearly all of our products are vegan, hypoallergenic and kosher.
d-light-trade and the D-Light-Full sales organisation are in close contact with self-awareness groups, patient initiatives and experienced patients. This means that the wealth of patient experience informs the development of new products.
d-light-trade currently specialises in vitamin D3 products for high-dose treatment of auto-immune diseases like multiple sclerosis, and complementary supplements. An overview of available products can be found in the online shop.
d-light-trade is the opposite of big pharma. The company pursues just one objective: providing high-quality food supplements, preferably from high-quality, sustainable production, to treat chronically ill people reliably and simply.
d-light-trade invests all its profits in high-quality, sustainable production, new products, scientific research into complementary treatments, and the work of self-help groups and patient initiatives.
Orthomolecular treatment with ultra-high doses of vitamin D3, known as ultra-high-dose vitamin D therapy, is an extremely effective option for improving quality of life for many people with multiple sclerosis.
Read more abut the Ultra-high-dose vitamin D therapy here >>
Between 2019 and 2025, D-light-full supported the first major longitudinal study in Germany, conducted at the Charité in Berlin, into the effects of high-dose vitamin D3 therapy for multiple sclerosis (MS), following on from the ultra-high-dose vitamin D therapy trial. The results are expected to be published by the end of 2026. We provided vouchers worth €60,000 for study participants. This ensured that all participants used a high-quality vitamin D supplement with a guaranteed dosage and high bioavailability. We would like to thank Coimbraprotokoll gUGmbH and the NeuroCure Research Centre at the Charité for their trust in our products!
Do you have questions about d-light-trade or about our dietary supplements and supplements? Then write us a short message.
